Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for USA stock SUPN Supernus Pharmaceuticals. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 51.77 and Closed at: 51.57, which is -0.39% of previous session's close. It moved within a range of 51.29 and 52.02
The session was a Bearish session with an average volume of 366300, which is 42.94% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 3 days back on mid term averages
Support for tomorrow is 51.07 and resistance for tomorrow is 51.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 51.23, 50.9 resistance for tomorrow's hourly charts is 51.96, 52.36
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 49.88 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 47.7 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 48.53 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 47.04 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 39.73 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 47.7 and 200 DMA is at 39.73, while 50 DMA and 100 DMA are at 48.53 and 47.04 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 47.7 and 20 EMA is at 48.8
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Fri Dec | 51.57 | 47.7 | 48.8 |
| 24 Wed Dec | 51.77 | 47.44 | 48.51 |
| 23 Tue Dec | 51.71 | 47.15 | 48.17 |
| 22 Mon Dec | 51.50 | 46.82 | 47.8 |
| 19 Fri Dec | 51.48 | 46.51 | 47.41 |
| 18 Thu Dec | 49.28 | 46.18 | 46.98 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 48.53 and 50 EMA is at 47.76
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Fri Dec | 51.57 | 48.53 | 47.76 |
| 24 Wed Dec | 51.77 | 48.48 | 47.6 |
| 23 Tue Dec | 51.71 | 48.43 | 47.43 |
| 22 Mon Dec | 51.50 | 48.36 | 47.26 |
| 19 Fri Dec | 51.48 | 48.31 | 47.09 |
| 18 Thu Dec | 49.28 | 48.27 | 46.91 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 47.04 and 100 EMA is at 45.74
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Fri Dec | 51.57 | 47.04 | 45.74 |
| 24 Wed Dec | 51.77 | 46.95 | 45.62 |
| 23 Tue Dec | 51.71 | 46.81 | 45.5 |
| 22 Mon Dec | 51.50 | 46.65 | 45.37 |
| 19 Fri Dec | 51.48 | 46.48 | 45.25 |
| 18 Thu Dec | 49.28 | 46.3 | 45.12 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 39.73 and 200 EMA is at 42.06
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Fri Dec | 51.57 | 39.73 | 42.06 |
| 24 Wed Dec | 51.77 | 39.63 | 41.96 |
| 23 Tue Dec | 51.71 | 39.53 | 41.86 |
| 22 Mon Dec | 51.50 | 39.43 | 41.76 |
| 19 Fri Dec | 51.48 | 39.34 | 41.66 |
| 18 Thu Dec | 49.28 | 39.24 | 41.56 |
Supernus Pharmaceuticals has performed better than Medtronic Plc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Tonix Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Tg Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Regeneron Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Novocure in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Neogenomics Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Lexicon Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Kalvista Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Ironwood Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Inmune Bio in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Hologic Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Hutchison China in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Enanta Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 6.21% more returns!
Dare Bioscience has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Dare Bioscience, about 3.73% more returns!
Supernus Pharmaceuticals has performed better than Collegium Pharmaceutical in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Audentes Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Assertio Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 1230.12% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.07 and Supernus Pharmaceuticals SUPN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


